Engaging Primary Care Clinicians in Screening for Hypercortisolism

Author(s):

Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE,Ralph DeFronzo, MD

Medical experts explore why findings from this study are crucial for clinicians managing diabetes, particularly those in primary care settings, and how these insights can impact their approach to patient care.

EP: 1.Overview of the CATALYST Study for Hypercortisolism

EP: 2.Defining Difficult to Control Diabetes

EP: 3.CATALYST Trial Study Design

EP: 4.True Prevalence of Hypercortisolism

EP: 5.Coexisting Cardiometabolic Conditions and Hypercortisolism

Now Viewing

EP: 6.Engaging Primary Care Clinicians in Screening for Hypercortisolism

EP: 7.Spectrum of Hypercortisolism Presentations

EP: 8.Mifeprestone for Treatment of Hypercortisolism

EP: 9.Reconsidering Standard of Care for Hypercortisolism

Video content above is prompted by the following:

Why should clinicians who manage patients with diabetes, the majority of whom are in the primary care setting, care about the findings from this study?